Sept 24 (Reuters) – ADARx Pharmaceuticals, Inc. : * ADARX PHARMACEUTICALS ANNOUNCES PRICING OF UPSIZED $446.3 MILLION INITIAL PUBLIC OFFERING * ADARX PHARMACEUTICALS, – PRICES UPSIZED IPO OF
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Sept 25 (Reuters) - Saudi Arabia, Turkey and Pakistan will hold an urgent meeting of…
By Abhirup Roy SAN FRANCISCO, Sept 24 (Reuters) - Tesla is set to roll out…
NEW YORK, Sept 24 (Reuters) - Polymarket sued New York Attorney General Letitia James and…
By Tom Polansek CHICAGO, Sept 24 (Reuters) - Chicago Mercantile Exchange live cattle and feeder…
By Allison Lampert, Carlos Méndez and Mrinmay Dey Sept 24 (Reuters) - Airbus said on…
Sept 24 (Reuters) - OpenAI is set to preview a cybersecurity-focused AI model, GPT-6 Cyber,…